Lindbrook Capital, LLC Karyopharm Therapeutics Inc. Transaction History

Lindbrook Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	BUY	$2.84 - $3.92 $1,133 - $1,564	399 New	399 $1,000
Q3 2022 Nov 10, 2022	SELL	$4.08 - $5.82 $762 - $1,088	-187 Reduced 79.57%	48 $0
Q2 2022 Aug 01, 2022	BUY	$4.15 - $8.37 $975 - $1,966	235 New	235 $1,000
Q3 2021 Nov 05, 2021	SELL	$4.45 - $10.63 $2,558 - $6,112	-575 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$8.11 - $11.11 $4,663 - $6,388	575 New	575 $6,000
Q1 2021 Apr 28, 2021	SELL	$9.85 - $17.69 $31,520 - $56,608	-3,200 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$14.15 - $17.19 $44,416 - $53,959	3,139 Added 5145.9%	3,200 $50,000
Q3 2020 Nov 03, 2020	SELL	$14.14 - $19.71 $6,207 - $8,652	-439 Reduced 87.8%	61 $1,000
Q2 2020 Jul 27, 2020	BUY	$16.6 - $25.25 $8,300 - $12,625	500 New	500 $9,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $54.3M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.